Biotech — European UPC Patent Cases
93 decisions indexed
Page 4 of 4 · 93 total
10x Genomics, Inc. v.NanoString Technologies Inc.
This UPC Court of Appeal decision addressed a request to suspend infringement proceedings due to the insolvency filing (Chapter 11) of one of the defendants. The court rejected the suspension request, establishing a key principle that procedural efficiency and fairness outweigh automatic suspension when the bankruptcy occurs after the oral hearing and the case is ready for judgment. This ruling provides clarity on how UPC procedures interact with foreign insolvency laws.
10x Genomics, Inc. v.Vizgen, Inc.
In this UPC case concerning patent infringement, the court issued a complex order regarding document disclosure stemming from parallel US litigation. The respondent sought to introduce evidence related to non-technical issues (such as competitive practices) into the European proceedings. The court granted the submission of specific documents but imposed stringent confidentiality requirements ('Outside Attorneys' Eyes Only'), balancing the need for evidence with protecting trade secrets.
10x Genomics, Inc. v.NanoString Technologies Inc.
This UPC decision addressed a request for provisional measures concerning the unitary patent EP4108782 related to analyte detection methods. The court provided important guidance on the standard of proof required (preponderant likelihood) when assessing validity in provisional measures proceedings. While the main injunction requests were dismissed, the court granted specific relief regarding indirect infringement and imposed significant penalty payments against the defendants.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.